Roche gets FDA approval for ZIIHERA companion diagnostics
Roche has received FDA approval for companion diagnostic tests identifying patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.